Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.5.4 to v3.5.5, indicating a new release of the page content.
    Difference
    0.0%
    Check dated 2026-06-05T09:55:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, representing a new version of the page. This change is a metadata update and does not modify the study content, eligibility criteria, or listed results.
    Difference
    0.0%
    Check dated 2026-05-15T06:59:06.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.2 to v3.5.3. This indicates a new revision of the page content.
    Difference
    0.0%
    Check dated 2026-04-30T18:44:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:05:59.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Revision updated to v3.5.0 (replacing v3.4.3).
    Difference
    0.0%
    Check dated 2026-03-18T19:43:02.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T17:55:53.000Z thumbnail image

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.